Investec Bank plc has filed a Form 8.5 regulatory disclosure relating to share dealings in Advanced Medical Solutions Group Plc (AMS.L).
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc is acting as Advisor and Joint Broker to Advanced Medical Solutions Group Plc in connection with the relevant offer period.
The dealings covered in the disclosure were undertaken on 19th June 2026, with the formal disclosure itself published on 22nd June 2026.
In terms of share activity, Investec purchased 145 ordinary shares in Advanced Medical Solutions Group at a price of 226 pence per unit.
On the sales side, the bank sold 25,145 ordinary shares, with prices ranging from a low of 229 pence to a high of 230.25 pence per unit.
The disclosure confirms that no cash-settled derivative transactions or stock-settled derivative transactions were undertaken as part of these dealings.
Investec also confirmed there are no indemnity or option arrangements, or any agreements or understandings relating to options or derivatives connected to these dealings.
The filing states that no other parties to the offer required separate disclosure, with the relevant section marked as not applicable given the nature of the transaction.
Advanced Medical Solutions Group Plc is a specialist medical device company, and its shares trade on the London Stock Exchange under the ticker AMS.L, which moved down 1.49% around the time of the disclosure.
The contact named in the filing is Priyali Bhattacharjee, and public disclosures of this nature under Rule 8 of the Takeover Code are required to be made to a Regulatory Information Service.
